Science Corporation, a startup established by Max Hodak, the former president of Neuralink, has announced plans to venture into the realm of organ preservation technology. This new initiative aims to enhance the longevity of human organs, a departure from the company’s previous focus on neural interfaces and vision restoration.
Based in Alameda, California, Science Corporation is working to advance current perfusion systems used for organ preservation. These systems, which maintain the circulation of blood through vital organs in transplant scenarios or as life-support mechanisms, are currently cumbersome and expensive. The company envisions developing a more compact and portable system that can offer prolonged organ support.
Previously focused on neural interfaces and vision improvement, Science Corporation is now expanding its technological pursuits to include organ preservation. The company’s innovative approach involves utilizing living neurons instead of conventional wires to establish connections with the brain. Additionally, Science Corporation is progressing towards the commercialization of its retinal implant, which has exhibited promising outcomes in individuals with advanced macular degeneration.
Hodak, the former Neuralink co-founder, was inspired to explore organ preservation following a specific medical case involving a teenager awaiting a lung transplant. This shift in the startup’s technological focus signifies a broader commitment to enhancing human health and longevity.
Source: WIRED
Leave a Reply